Northwest Investment Counselors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $18.5K | Buy |
+127
| New | +$18.5K | ﹤0.01% | 357 |
|
|
2024
Q2 | – | Sell |
-127
| Closed | -$17.4K | – | 312 |
|
|
2024
Q1 | $17.4K | Buy |
+127
| New | +$17.4K | ﹤0.01% | 327 |
|
|
2023
Q4 | – | Sell |
-127
| Closed | -$15.5K | – | 318 |
|
|
2023
Q3 | $15.5K | Hold |
127
| – | – | ﹤0.01% | 338 |
|
|
2023
Q2 | $16.1K | Hold |
127
| – | – | ﹤0.01% | 336 |
|
|
2023
Q1 | $16.4K | Hold |
127
| – | – | ﹤0.01% | 350 |
|
|
2022
Q4 | $16.7K | Sell |
127
-250
| -66% | -$32.8K | ﹤0.01% | 349 |
|
|
2022
Q3 | $44K | Buy |
377
+250
| +197% | +$29.2K | 0.01% | 227 |
|
|
2022
Q2 | $15K | Hold |
127
| – | – | ﹤0.01% | 324 |
|
|
2022
Q1 | $17K | Buy |
+127
| New | +$17K | ﹤0.01% | 334 |
|
|
2021
Q2 | – | Sell |
-200
| Closed | -$30K | – | 275 |
|
|
2021
Q1 | $30K | Buy |
+200
| New | +$30K | 0.01% | 265 |
|
|
2017
Q4 | – | Sell |
-300
| Closed | -$33K | – | 211 |
|
|
2017
Q3 | $33K | Hold |
300
| – | – | 0.01% | 210 |
|
|
2017
Q2 | $31K | Buy |
+300
| New | +$31K | 0.01% | 197 |
|